Viewing Study NCT00909532

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:00 PM
Ignite Modification Date: 2026-05-23 @ 12:24 PM
Study NCT ID: NCT00909532
Status: COMPLETED
Last Update Posted: 2013-01-18
First Post: 2009-05-26
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older With the G551D Mutation
Sponsor: Vertex Pharmaceuticals Incorporated
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cystic Fibrosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Fibrosis View
None Pancreatic Diseases View
None Lung Diseases View
None Respiratory Tract Diseases View
None Genetic Diseases, Inborn View
None Infant, Newborn, Diseases View
None Pathologic Processes View